Appia Bio is an early stage biotechnology company based in Los Angeles, California. Founded in 2020, Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).
Location: United States, California, Los Angeles
Employees: 11-50
Total raised: $52M
Founded date: 2020
Investors 3
| Date | Name | Website |
| 12.05.2021 | Two Sigma ... | twosigmave... |
| - | Freeflow V... | freeflow.i... |
| - | Axial VC | axialvc.co... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 21.05.2021 | Series A | $52M | Two Sigma ... | prnewswire... |
Mentions in press and media 7
| Date | Title | Description | Source |
| 14.01.2022 | Our 2021 Predictions Report Card: How Accurate Were We? | Each year we pause to reflect on what happened in the tech and VC space and share new predictions fo... | twosigmave... |
| 12.08.2021 | Appia Bio Inks Mega Deal To Scale Cancer Therapies | The next wave of cancer treatments uses the body's own immune system rather than chemotherapy or rad... | dot.la/app... |
| 21.05.2021 | Appia Bio Raises $52M in Series A Financing | Appia Bio, Inc., a Los Angeles, CA-based early stage biotechnology company developing engineered all... | finsmes.co... |
| 11.05.2021 | Appia Bio Launches With $52 Million Series A Financing and E... | LOS ANGELES, May 11, 2021 /PRNewswire/ -- Appia Bio, Inc., an early stage biotechnology company de... | prnewswire... |
| 11.05.2021 | Appia Bio Comes Out of Stealth Aiming to Offer Faster, Safer... | Cell therapy has taken the oncology world by storm. For cancer patients who have tried every other ... | dot.la/all... |
| 11.05.2021 | Appia Bio : Launches With $52 Million Series A Financing and... | LOS ANGELES, May 11, 2021 /PRNewswire/ -- Appia Bio, Inc., an early stage biotechnology company deve... | marketscre... |
| 11.05.2021 | Appia Bio Takes $52M For Stem Cell Therapy | Los Angeles-based Appia Bio, a biotech startup focused on developing engineered allogeneic cell ther... | socaltech.... |